Jan 28, 2026 Articles, Diabetes, Feature, Therapies, Type 2 Diabetes, Type 2 Diabetes 5,878 views For decades, metformin has been the backbone of type 2 diabetes therapy
5.1 Challenges encountered in preclinical trials Several drugs have been shown to inhibit ferroptosis in animal experiments, but they mostly suffer from low stability, low solubility, low targeting, low safety, toxicity, poor pharmacokinetics, and low activity (Guo et al., 2023), so very few of them have entered clinical studies
Anticoagulant medicines (e.g., warfarin): Concurrent use may increase the effect of anticoagulants and increase the risk of bleeding in some individuals
BPC-157: Nitric Oxide System Modulation BPC-157 is a 15-amino acid peptide originally found in human gastric juice
In conclusion, the promise of GLP-1 RAs for weight management in patients without diabetes in Poland remains largely unrealized